These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 2139513

  • 1. Effects of thromboxane A2 on thoracic aorta of young and old rats: use of selective thromboxane receptor antagonists.
    Shams G, Wallace LJ, Miller DD, Feller DR.
    Pharmacology; 1990; 40(1):27-32. PubMed ID: 2139513
    [Abstract] [Full Text] [Related]

  • 2. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
    Mukhopadhyay A, Navran SS, Amin HM, Abdel-Aziz SA, Chang J, Sober DJ, Miller DD, Feller DR.
    J Pharmacol Exp Ther; 1985 Jan; 232(1):1-9. PubMed ID: 3855323
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological evaluation of the beta-adrenoceptor agonist and thromboxane receptor blocking properties of 1-benzyl substituted trimetoquinol analogues.
    Shams G, Romstedt KJ, Gerhardt MA, Harrold MW, Miller DD, Feller DR.
    Eur J Pharmacol; 1990 Aug 02; 184(1):21-31. PubMed ID: 1976530
    [Abstract] [Full Text] [Related]

  • 4. Halogen-substituted trimetoquinol analogs as thromboxane A2 receptor antagonists in platelets and aorta.
    Romstedt KJ, Shin Y, Shams G, Doyle K, Tantishaiyakul V, Clark MT, Adejare A, Hamada A, Miller DD, Feller DR.
    Biochem Pharmacol; 1993 Dec 03; 46(11):2051-9. PubMed ID: 8267653
    [Abstract] [Full Text] [Related]

  • 5. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
    Furci L, Fitzgerald DJ, Fitzgerald GA.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):74-81. PubMed ID: 1830100
    [Abstract] [Full Text] [Related]

  • 6. Interactions of nonprostanoid trimetoquinol analogs with thromboxane A2/prostaglandin H2 receptors in human platelets, rat vascular endothelial cells and rat vascular smooth muscle cells.
    Shin Y, Romstedt KJ, Miller DD, Feller DR.
    J Pharmacol Exp Ther; 1993 Dec 01; 267(3):1017-23. PubMed ID: 7903383
    [Abstract] [Full Text] [Related]

  • 7. Pharmacologic antagonism of thromboxane A2 receptors by trimetoquinol analogs in vitro and in vivo.
    Shin Y, Romstedt KJ, Doyle K, Harrold MW, Gerhardt MA, Miller DD, Patil PN, Feller DR.
    Chirality; 1991 Dec 01; 3(2):112-7. PubMed ID: 1830752
    [Abstract] [Full Text] [Related]

  • 8. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle.
    Dorn GW, Becker MW, Davis MG.
    J Biol Chem; 1992 Dec 05; 267(34):24897-905. PubMed ID: 1447225
    [Abstract] [Full Text] [Related]

  • 9. Thromboxane A2 stimulated signal transduction in vascular smooth muscle.
    Dorn GW, Becker MW.
    J Pharmacol Exp Ther; 1993 Apr 05; 265(1):447-56. PubMed ID: 8474027
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
    Harris DN, Michel IM, Goldenberg HJ, Hartl KS, Allen GT, Steinbacher TE, Schumacher WA, Han WC, Hall SE, Floyd DM.
    J Pharmacol Exp Ther; 1992 Apr 05; 261(1):131-7. PubMed ID: 1532833
    [Abstract] [Full Text] [Related]

  • 11. Specific receptors for thromboxane A2 in cultured vascular smooth muscle cells of rat aorta.
    Hanasaki K, Nakano K, Kasai H, Arita H, Ohtani K, Doteuchi M.
    Biochem Biophys Res Commun; 1988 Feb 15; 150(3):1170-5. PubMed ID: 2963633
    [Abstract] [Full Text] [Related]

  • 12. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
    Greenberg SS, Johns A, Kleha J, Xie J, Wang Y, Bianchi J, Conley K.
    J Pharmacol Exp Ther; 1994 Mar 15; 268(3):1352-61. PubMed ID: 8138950
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
    Ahn CH, Romstedt KJ, Wallace LJ, Miller DD, Feller DR.
    Biochem Pharmacol; 1988 Aug 01; 37(15):3023-33. PubMed ID: 3134894
    [Abstract] [Full Text] [Related]

  • 14. Receptor-mediated mitogenic effect of thromboxane A2 in vascular smooth muscle cells.
    Hanasaki K, Nakano T, Arita H.
    Biochem Pharmacol; 1990 Dec 01; 40(11):2535-42. PubMed ID: 2148480
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological evaluation of the beta-adrenoceptor agonist and thromboxane antagonist properties of N-substituted trimetoquinol analogues.
    Fedyna JS, Adejare A, Miller DD, Feller DR.
    Eur J Pharmacol; 1987 Mar 17; 135(2):161-71. PubMed ID: 2884118
    [Abstract] [Full Text] [Related]

  • 16. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
    Mais DE, Saussy DL, Chaikhouni A, Kochel PJ, Knapp DR, Hamanaka N, Halushka PV.
    J Pharmacol Exp Ther; 1985 May 17; 233(2):418-24. PubMed ID: 2987481
    [Abstract] [Full Text] [Related]

  • 17. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles.
    Ogletree ML, Allen GT.
    J Pharmacol Exp Ther; 1992 Feb 17; 260(2):789-94. PubMed ID: 1531361
    [Abstract] [Full Text] [Related]

  • 18. Effect of endothelin antagonists on the responses to prostanoid endothelium-derived contracting factor.
    Moreau P, Takase H, Lüscher TF.
    Br J Pharmacol; 1996 Jul 17; 118(6):1429-32. PubMed ID: 8832068
    [Abstract] [Full Text] [Related]

  • 19. Effects of the new thromboxane A2 antagonist vapiprost on isolated canine blood vessels.
    Matsuzaki T, Noguchi K, Nakasone J, Uezu K, Higuchi M, Sakanashi M.
    Arzneimittelforschung; 1992 Nov 17; 42(11):1318-22. PubMed ID: 1492844
    [Abstract] [Full Text] [Related]

  • 20. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
    Krauss AH, Woodward DF, Gibson LL, Protzman CE, Williams LS, Burk RM, Gac TS, Roof MB, Abbas F, Marshall K, Senior J.
    Br J Pharmacol; 1996 Mar 17; 117(6):1171-80. PubMed ID: 8882612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.